<SEC-DOCUMENT>0001104659-11-035285.txt : 20110617
<SEC-HEADER>0001104659-11-035285.hdr.sgml : 20110617
<ACCEPTANCE-DATETIME>20110617093857
ACCESSION NUMBER:		0001104659-11-035285
CONFORMED SUBMISSION TYPE:	FWP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20110617
DATE AS OF CHANGE:		20110617

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERIT MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000856982
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870447695
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		FWP
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-169012
		FILM NUMBER:		11917195

	BUSINESS ADDRESS:	
		STREET 1:		1600 WEST MERIT PARK WAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		8012531600

	MAIL ADDRESS:	
		STREET 1:		1600 WEST MERIT PARKWAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERIT MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000856982
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870447695
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		FWP

	BUSINESS ADDRESS:	
		STREET 1:		1600 WEST MERIT PARK WAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		8012531600

	MAIL ADDRESS:	
		STREET 1:		1600 WEST MERIT PARKWAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
</SEC-HEADER>
<DOCUMENT>
<TYPE>FWP
<SEQUENCE>1
<FILENAME>a11-14744_3fwp.htm
<DESCRIPTION>FWP
<TEXT>


<html>
<head>


  </head>
<body lang="EN-US">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Issuer Free Writing Prospectus Dated June&nbsp;17, 2011</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Filed Pursuant to Rule&nbsp;433</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Relating to Preliminary Prospectus Supplement dated June&nbsp;16, 2011</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Relating to Registration No.&nbsp;333-169012</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-weight:bold;"><img width="252" height="62" src="g147443bci001.jpg"></font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Merit Medical Systems,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,800,000 Shares of Common Stock</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This free writing prospectus relates only to the securities described in, and should be read together with, the preliminary prospectus supplement dated June 16, 2011 (the &#147;Prospectus Supplement&#148;). The following information supplements and updates the information contained in the Prospectus Supplement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Issuer:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Merit   Medical Systems,&nbsp;Inc.</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NASDAQ   Symbol:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">MMSI</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Common   Stock Offered By the Issuer:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,800,000   shares</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Underwriter&#146;s   Over-Allotment Option:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30-day   option to purchase up to 720,000 additional shares of Common Stock to cover   over-allotments, if any</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Price   to the Public:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$16.75</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gross   Proceeds:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$80,400,000   (not including the Underwriter&#146;s 15% over-allotment option)</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net   Proceeds:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Approximately   $76.1 million, after deducting underwriting discounts and commissions and   estimated offering expenses</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Use   of Proceeds:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Merit   Medical Systems,&nbsp;Inc., intends to use the net proceeds from this   offering to repay approximately $25 million of indebtedness under its   unsecured credit agreement, to expand its manufacturing facilities, for   potential strategic acquisitions and for general corporate purposes</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Trade   Date:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">June&nbsp;17,   2011</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing   Date:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">June&nbsp;22,   2011</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CUSIP:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">589889104</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Underwriter:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Piper   Jaffray&nbsp;&amp; Co.</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lock-Up   Provisions:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The   Company, its executive officers and directors have entered into 90-day   lock-up agreements with the underwriter</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Eligibility:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No   eligibility restrictions in the United States</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Merit Medical Systems,&nbsp;Inc. filed a registration statement (including a base prospectus and a preliminary prospectus supplement thereto) with the Securities and Exchange Commission (the &#147;SEC&#148;) for the offering to which this communication relates.&#160; Before you invest, you should read the base prospectus and the preliminary prospectus supplement thereto in that registration statement (including the documents incorporated by reference therein) and other documents Merit Medical Systems,&nbsp;Inc. filed with the SEC for more complete</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rcheney\11-14744-3\task4730580\14744-3-bc.htm',USER='rcheney',CD='Jun 17 08:26 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">information about Merit Medical Systems,&nbsp;Inc. and this offering.&#160; You may obtain these documents for free by visiting EDGAR or the SEC website at www.sec.gov.&#160; Alternatively, a written prospectus and accompanying preliminary prospectus supplement related to the offering may be obtained from Piper Jaffray&nbsp;&amp; Co. at 800 Nicollet Mall, Minneapolis, MN 55402, Attention: Equity Capital Markets, or by telephone at (800) 747-3924.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ANY DISCLAIMER OR OTHER NOTICES THAT MAY&nbsp;APPEAR AFTER THIS MESSAGE ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rcheney\11-14744-3\task4730580\14744-3-bc.htm',USER='rcheney',CD='Jun 17 08:26 2011' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g147443bci001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g147443bci001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"``^`/P#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HKQK_A/O$__03_`/($?_Q-20>-_%=Q*(XM1W,>?]3$
M`!W))7`'O6?M$>L\IKKJOQ_R/8:*\LMM;\?7DDB6LLDWEJ&9DAA*X/3#8P?P
MJ#_A*O&GE>9]K;_<\B+?UQG;MW8SQG&*?.B/[,J7MSQ^_P#X!ZU17D^H^)?'
M&D^7]ON)+?S1E-]O%S_X[U]J[[PC?W6J>&+2\O)?-GDW[GVA<X=@.!QT`IJ2
M;L8U\'.C351M-/30VJ**Y_5?&NC:/?\`V&YED:5<;_+3<$SZ_P#UJ;:1RTZ<
MZCM!79T%%9>J^(=-T?3X[ZZF)BFQY0C&XR9&>/PK$_X69H/]R[_[]#_&AR2-
M(8:M45XQ;1U]%<]IGC?1-4:98Y9(3!&96\Y,?*.I&,]*I'XEZ`"0%NS[B(<_
MK2YD4L)7;:Y'H==17+6WQ%\/W,ZQ-)/!N.-\L>%'U()Q6KK7B+3M!MHI[R1B
M)CB-8QN+^I'MR/SIW1,L/6C)1<7=FI17(?\`"S-!_N7?_?H?XT?\+,T'^Y=_
M]^A_C2YD7]3Q'\C.OHKG]&\::1K=\+*V:9)F!*K*F-V.3C!/:K=[X@M[.ZDM
MTMKNZ:$!IC;1;Q$#R-W/7'.!DT[HS="K&7*XZFK16=<ZW906MM.A>X^UX^SI
M`A9Y>,Y`]`.3GI4?]N/_`-`;4_\`ORO_`,51<E4IO6QJT5D?\)+8Q^<+N.XL
MGB3S-EQ%@NN0,KC.>2!@<\THUUB,C1M4P>?]0!_[-1=#]C/L:U%94'B+3Y)T
MMYC-9S.<)'=Q-$6^A/!_`U-J&KV^GRQ0M'-//,"4A@CWN0.I]ASWHNA>RG>U
MB_152SU.TOK(W<4FV-21)Y@V&,CJ&!Z$53'B2UF8_8K6]O4'_+6W@)3\&.`?
MPS1=`J4VVK;&O16;9Z[97ER+4^;;71&1!<QF-V'MG@_AFEO-;M;.Z%HL<]U<
MX#&&VC+LH]6[#\31=![*=[6U-&BL^QUFVOIVM@DUO<H-Q@N(RC[?4=B/<9I;
M;6].O+O[+!<[I^?W;(RGCKU`]:+H3IS5]-B_1113(/GBM:.RFCL(X(E/VB]V
MEAL8G9GY5X'\1P?P6JVEVD=S=;IR!;PC?*2P7([*"2!DGC\SVKOO!>CK>W\F
MMW*QOL;]T1&@!?N058]!QCW]JYXJY]ABL0J4;OI^?0W].MXO"/A-$G;?]FC+
M2$9.YR<X'XG`KE_!6FW>J^))_$5ZY^1FQ@$9=AC'(Z!3_*K/BZ^.LZM#H=K(
MCA'PR_(VY_H7!X&>WK72PBR\-:=9V*;!OD2%%!"EW8@$X)]R<?A6N[\D>'S2
MITF_MU/R_P""87Q-A,VC6@7J+CT)_A/H*U/`J&/P?8H>H\SL1_RT;UJE\0E1
M])M@Y0#S_P",*?X3_>9:T/!H5?"MF$*D?/C:!C[[>A(_6C[1$W_L,5_>_P`R
MYKVKQ:'H\]_)@E!B-3_&YZ#_`#VS7AMQ<2W5Q)<3N7EE8L['N376?$/7O[1U
M8:?`^;>S)#8/#2=_RZ?G7)S0R0.$E0HQ56P?1@"/T(K.;NSV,MP_LJ7,]Y?D
M7]9UF355L8>1#96L<**?4*`Q_$C\@*32M/L+Y9#>ZO'8%"-H>)GW_E5$02&W
M:<(?*5PA;MD@D#]#6IH7AF[\0),]M<VL(A(#>>Y7.<],`^E3NSLGR4Z=D^5(
MV[7P]I5OH.JZA:ZPFH2Q6Y0*D939GN0>3QD?G7-Z+IBZMJ*VKW26J;&=I7&0
MH4$G/Y5UL/A:3P_X=UFXNKVWEEEMO+5(7)&,@Y.0.>*YKPSIQU;538J^QIH)
M`K=@=I(S[9%-K8Y:56\*DE.]NOR(-6L+*Q>-;+5([\,#N*1LFS\^M7M6N9KG
MPGH7G$GRGN(T)[J"F/RZ?A6.(1#>>3=AXPDFV4`?,N#@_CUKKO'R:=!INB6V
MF21O;Q)+MV.&.#L.3[GDT+9FLY6J4XO5W>OR93T+P9_;>A3:I_:'D>4SCR_)
MW9V@'KN'KZ5B:/I_]JZM;6'F^5Y[[=^W=M_#(KT+P)_R(MY_OR_^@"N)\(?\
MC9IW_78?R--I:&-.O4;K7?P[?B=C8>#X?"+MK5S>&[E@!%O"D>W=(WRJ.IR2
M3C]:ZW1=/;3M/"3,'N9F,UPX_BD;D_@.@]@*I_\`(8\0_P!ZSTIOP>X(_P#9
M`?S;VJSI6KQZK<7ZPX,5K/Y(8?Q$`$G\R1^%:I)'A5ZE6I&\W=Z7_1?K_P`,
M9'@VRFDMDU&[7;LC,%JG]R/.2WU8_H!5O6]9U:PU%;>RTX3PF$.96BF8;B2"
MOR*W0`'GUJW<:M#;:W8Z/$J[YU9F`_@15./S(_0U!J?B`V&I_84@A<B%92\U
MTL(Y9A@9'/W?UHV07E4J\SC>ZO;R.=OY[C6/)O;V6%);*YAC6UC1U9"\J99M
MX!Y"C'&.M=5JM]>6]S9VUC'`\MRSC,S$*-JY[5S&ISB]N!?SSV4<K2VT$5O!
M<K*Q43!BQ(_ITYKH]2(&NZ02<`/-_P"BS21I52]U6VOI\K_F-CNQJ$SZ/K6G
MQQRR1EE7=YD4RC@E3@<C(X(!'!K/T.*XM/%EW8SNTJ6UHJV\KG+&,L2`3W(Y
M&?:K<MU%JGB2Q2R99DL/,DN)4.54LA4)GIDYSC_9I+>>.;QU>(AR8;"-']CO
M9OY,*9"NHR5K75[=M?\`+\RA:63ZKXBU6SN!_P`2^WNQ,\8Z3R&-``WJHVDD
M=R16I_:UY<SR0:-I\4L-NQC:>:7RX]PZJH`)..F>!46A7,9U_7K7(\Q;E),>
MH,:C^E,T/4+72[8Z1?SQVMS;._$K!1*I8D.I/4'/YYI(=2[Z7LEIZK5E;6[^
M^>U@EN](:V^QSI.\IE5@2IX6/')+'"\@=3FK:3Q^%O#TNHZD=]S*WFW!7J\C
M?PCV'0>PI5FC\0:S"\#>9IU@=_F#[DTW0`'N%'.?4CTJ'Q1HFIZU*J6_V5K9
M8'55FD92LK9&_`4YPO3ZFCS&G%N-.>BW?^6O]?<7M;11>:3<+Q*EZ$##KM9&
M##Z'C\JT$LK2*8S1VL*2$YWK&`WYUF^()8X?[-DE=8T6^0LS'`'RMWJ['JNG
M2R+''?VSNQP%6923^&:KJ<S4G"-O/\RW1FBBF8'B>D:A9P:>]O,6C?S?,+"1
MTWKC`'RCDCG&>/F/(KL;3XA:-9:)%'#!<":/Y1">3U^\6/7U^M3_`/"L=$_Y
M^K__`+^)_P#$4?\`"L=$_P"?J_\`^_B?_$5DE)'O5L1@JS]]LQM#\3Z/INJ^
M?<M-+Y@;]Z)9)`F?4-CD\].GOFIM3\9Z9>ZQ!>J\_D6C`K'O=6<@YR%'RG/'
MWB*T_P#A6.B?\_5__P!_$_\`B*/^%8Z)_P`_5_\`]_$_^(HM(EUL$Y\[;OL9
M?BKQOIFHV]O#9QSS8;>YWM#MXQCCKU^E=3X4F:\\'V\D&Z)W60)N<N5.]@#D
M\FLK_A6.B?\`/U?_`/?Q/_B*Z72-,@T;3(=/MFD>*'=M,A!8Y8GG`'<U24KW
M9RXBKAO8J%&^CZ_,\ST7P1JMUKB1ZG:216T;[II'/#@<X![Y]15OQIX7U:Y\
M32W-E8O/!<*FPQCA<*%P?3I7IU&:.16L/^TZOM%4LMK6.!UKP=<V_@JTLK&'
MS[F&833A.KDJ0<>N.!]!7'?\(OKW_0(N_P#OT:]OHS0X)CHYG5IIII/6YXA_
MPB^O?]`B[_[]&NE\">&]5M?$"WMW9R6T,*-S*NTL2,``?C7I5%)028ZN:5*D
M'#E6IYWX[\)7<^IC4M,M7G$XQ,D8R0P[X]Q^H]ZY,>&==)(_LB\X_P"F+5[A
M1FAP384<TJTX*%D[',>#]'O+'PE)9W<?DS3EV"MU4,,#/Y5R7A?PIK5OXF@D
MN+-[>.V8LTKCY>`<8]><=*]4HJN5:&$<=4CSZ+WCD[*ZN[;0ET:VL[J/57RD
MDC1-L5F/S2E^A')(YST&*GLC%X7N[NU:TNFMY1&]NT$+2;]L:H5.T<-E<\]<
MUTM&:+&3KIW36CW.56SO+.:VU^YM9);B2=I+F*(;GBC*%44`==HQG'J:M3ZU
MH=TXDN=-N)G`P&DTUV('IRM=!13L)UE)WDON=M#G%U/PZCATTB564Y!&F."#
M_P!\U1U^677Y+1[33KR6TLW\RZ#1-$94)`**#@L<9R/P[UV-&:5BHUU&2DD[
M^;,--5+1"UT'29/9Y8#!#'[G(!/T`JI#:GPWJBW<\<]TES`5N;F*(NWF[LY*
MKD@$'`],`5T]%.Q*K)726CW[OYG,VVEWERUQK-JIL[U[EI(%G4CS(BJ+LD'4
M`[,^HXJS+J]O(@BUG1;F-E/0VQN(\_[+*#_(5NYHHL#K<S]Y>G=&(;_4-0"V
MVD64EC",!KJZAV!1Z)&>2?K@43:=XA6!S#KZO(%)16LT`)QP">U;=%%B?;6^
M%+[K_F81\164L*QW^G7J2C&^)[)W"M[$`@_454OKW1[^QFMH=%N)I9$(1!8,
MGS=CN(`7ZYXKJ**+,I581=TG]_\`P""PCGATZVBN7WSI"BRMG.Y@!D_G5BDH
(S3,&[NY__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
